medigraphic.com
ISSN 1029-3035 (Electronic)

2012, Number s1

<< Back Next >>

Mediciego 2012; 18 (s1)

Associated ocular diseases and risk factors in old people with age-related macular degeneration

Hernández BR, Triana CI, Ramos GEA, Beltrán SRI

Language: Spanish
References: 26
Page:
PDF size: 57.68 Kb.


ABSTRACT

Introduction: The age-related macular degeneration is a leading cause of disability in people older than 60 years around the world. Method: A descriptive and traverse investigation, in the health area “Héroes de Girón” of Cerro municipality was carried out during the year 2007, whose universe was constituted by 651 old people with visual dysfunctions not resolved with optic correction and a sample of 230 patients with age-related macular degeneration, after having applied the inclusion approaches (voluntary acceptance of participating in the study) and exclusion (absence of psychiatric or organic disease that prevented him to participate appropriately). The variable age, sex, color of the skin, personal and family, systemic and ocular pathological antecedents and risk factors were analyzed. Results: prevailed the patients between 70 and 79 years (72.61%), women (66.09%), white skin (66,09%). Between the systemic and oculars, personal and family pathological antecedents, the vascular disease or with important vascular component were the most represented. Among the risk factors, cardiovascular diseases prevailed (85.21%), possibly influenced by the rest of them (smoking habit, sedentary life and inadequate diet). Heritage was present in 31.30% of patients. Conclusions: the most representative thing in the analyzed series is the interaction of the vascular factor with other conditions that can generate, to aggravate and to strengthen the effects of the tissular ischemia, besides the heritage and age in the complex system of the risk factors associated to the disease.


REFERENCES

  1. Rothman KJ. Modern Epidemiology 1 ed. Boston: Little Brown; 1986: 32-41.

  2. GeriCuba. Red Cubana de Gerontología y Geriatría [sitio en Internet]. Cuba es ya un ejemplo de país en desarrollo con un envejecimiento importante [actualizado may 2007; citado may 2007]. Disponible en: http:www.sld.cu/sitios/gericuba/temas.php?idv=13176

  3. Reichel W. Aspectos clínicos del envejecimiento. Buenos Aires: El Ateneo; 1978:65-8.

  4. Carrasco García M. Lograr una buena longevidad. La Habana: Editorial Científico-Técnica; 2005:53-82,143.

  5. National Eye Institute. Vision problems in the US: prevalence of adult vision impairment and age-related eye disease in Americans. Maryland: Bethesda; 2002:56-62.

  6. Marticorena J, Gómez-Ulla F, Lago JR. Degeneración macular asociada a la edad. Madrid: Prous Science; 2005:29-31.

  7. Elmann MJ. Exudative age-related macular degeneration. En: Ryan SJ. Retina Vol. II. St. Louis: Mosby Company; 1989:175-200.

  8. Sedden JM. Epidemiology of age-related macular degeneration. En: Ryan SJ. Retina Vol. II. St. Louis: Mosby; 2001. p. 1039, 1065-9.

  9. Walters G. Five year’s incidence of age-related maculopathy: the visual impairment project. Evidence-Based Ophthalmol. 2004, 5(4):210.

  10. West SK, Muñoz B, Rubin GS, Schein OD, Bandeen-Roce K, Zeger S et al. SEE Project Team. Function and Visual Impairment in a Population-Based Study of Older Adults. Invest Ophthalmol Vis Sci. 1997; 38:72-82.

  11. Hernández E, García J, Arévalo MA, Barahona JM. Estudio bioquímico y morfológico del segmento posterior de ratas seniles tratadas con antioxidante EGB-761. Arch Soc Esp Oftalmol. 1997; 72:593-600.

  12. Hayat M, Ferris FL. Sunlight and the 10 year incidence of age-relates macular maculopathy. The Baever Dam Eye Study. Evidence-Based Ophthalmol. 2004, 5(4):218.

  13. Friedman DS, O’Colain BJ, Muñoz B. Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004; 122:564-72.

  14. Jonasson F, Arnarsson A, Sasaki H, Peto T. The prevalence of age-related maculopathy in Iceland. Arch Ophthalmol. 2002; 120:379-85.

  15. Tasman W, Rovner B. Age-related macular degeneration. Treating the whole patient. Arch Ophthalmol. 2004; 122:168-9.

  16. Rocabruno Mederos JC. Tratado de Gerontología y Geriatría Clínicas. La Habana: Editorial Científico-Técnica; 1999.

  17. Álvarez Sintes R. Temas de Medicina General Integral. La Habana: ECIMED; 2001.

  18. Salva A, Vellar B, Albarede JC. Evaluación gerontológica. Primeros resultados de una unidad de evaluación geriátrica. Rev Gerontol. 1994; 4:179-4.

  19. Isas Cordové M, Triana Casado I, Torres Martín L, Pérez Rodríguez L, Seuc Martínez AH. Algunos aspectos clínico-epidemiológicos en el preoperatorio de la catarata senil. Rev Cub Oftalmol. 2010; 23(supl.1).

  20. Linares Fernández ME. Factores asociados a la prevalencia de hipertensión arterial en una población industrial. Rev Cubana Salud Trab. 2001; 1(1):23-6.

  21. Morón Rodríguez F, Levy Rodríguez M. Farmacología general. La Habana: ECIMED; 2002.

  22. Oramas Viera A. El estilo de vida. Una propuesta instrumental para su caracterización. Rev Cubana Salud Trab. 2002; 1(1):14-22.

  23. Age-related macular degeneration: what you should know [Internet]. 2005 [actualizado ene 2007; citado jun 2007]. Disponible en: http://www.nei.nih.gov/health

  24. Fernández-Brito Rodríguez JA, Wong Navarro R, Contreras Delgado J. Aterosclerosis juvenil. Un registro revelador. Av Méd Cuba. 1998; 15(5):32-4.

  25. Lee SY. Current treatment options for choroidal Neovascular disease. Sing Vision. 2006; 14(3):4-5.

  26. Potter M, Szabo SM. Recurrence of choroidal neovascularization after photodynamic therapy in patients with age-related macular degeneration. Br J Ophthalmol. 2007; 91:753-6.




2020     |     www.medigraphic.com